BCMA-Targeting CAR T-Cell Therapy Is Feasible in Patients With Multiple Myeloma and CNS Involvement

by | Mar 21, 2025 | Myeloma News | 0 comments

Source: Pharmacy Times articles

Patients with central nervous system (CNS) involvement achieved favorable outcomes with chimeric antigen receptor (CAR) T-cell therapy.
Read More

You must be logged in to post a comment.